Crohn Disease Complicated by IgA Vasculitis-Associated Nephritis: Renal Outcomes After Ustekinumab-Maintained Intestinal Remission (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO0549; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "He was treated with methylprednisolone and tacrolimus, followed by maintenance therapy with ustekinumab, tacrolimus, and prednisone. Renal biopsy is essential for diagnosis and treatment guidance. Ustekinumab may maintain intestinal remission, but renal immune injury may still require glucocorticoids and immunosuppressants, with close monitoring of proteinuria, renal function, and drug levels."
Clinical • Crohn's disease • Gastroenterology • Gastrointestinal Disorder • Genetic Disorders • Glomerulonephritis • IgA Nephropathy • Immunology • Inflammation • Inflammatory Bowel Disease • Lupus Nephritis • Nephrology • Renal Disease • Vasculitis
|
|
Yu Qin; Juan Tang; Aimei Li; Bin Yi
|